[PragmaticPulp]

Of course it's not purely benevolent. Walmart is a business and this is a business move.

> A vial of analog insulin costs something like $6-7 to produce, probably less at Walmart scale. The distribution costs probably make the net cost somewhere still in the $7-10 range.

Don't forget the R&D costs of getting a generic drug approved and setting up the manufacturing. It may cost <$10 to produce at scale, but getting there isn't free.

Hopefully Walmart's pricing trends downward toward the $25/vial price of regular insulin.

Actually, I hope this move spurs more chain pharmacies to start developing their own analogs, furthering competition in the space. Race to the bottom would be great.

[brayhite]

Curious how often the “race to the bottom” versus the “planned price floor” applies to healthcare.

Sure, OTC stuff may differ given the different markets, but I’m highly skeptical of this spurring any sort of race to the bottom that doesn’t also come with large asterisks around quality, qualification to purchase, etc.